Verastem (VSTM) Competitors

Verastem (NASDAQ:VSTM) and OPKO Health (NASDAQ:OPK) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, risk, valuation, community ranking and profitability.

Do analysts rate VSTM or OPK?

Verastem presently has a consensus target price of $13.88, suggesting a potential upside of 111.19%. OPKO Health has a consensus target price of $2.75, suggesting a potential upside of 52.78%. Given Verastem's higher probable upside, equities research analysts clearly believe Verastem is more favorable than OPKO Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Verastem	0 Sell rating(s)	0 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	3.00
OPKO Health	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Does the MarketBeat Community believe in VSTM or OPK?

Verastem received 105 more outperform votes than OPKO Health when rated by MarketBeat users. However, 65.68% of users gave OPKO Health an outperform vote while only 65.32% of users gave Verastem an outperform vote.

Company	Underperform	Outperform
Verastem	Outperform Votes 616 65.32%	Underperform Votes 327 34.68%
OPKO Health	Outperform Votes 511 65.68%	Underperform Votes 267 34.32%

Does the media favor VSTM or OPK?

In the previous week, Verastem had 24 more articles in the media than OPKO Health. MarketBeat recorded 32 mentions for Verastem and 8 mentions for OPKO Health. OPKO Health's average media sentiment score of 0.92 beat Verastem's score of 0.19 indicating that OPKO Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Verastem	5 Very Positive mention(s)	8 Positive mention(s)	10 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
OPKO Health	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more volatility & risk, VSTM or OPK?

Verastem has a beta of 0.6, suggesting that its share price is 40% less volatile than the S&P 500. Comparatively, OPKO Health has a beta of 1.7, suggesting that its share price is 70% more volatile than the S&P 500.

Which has stronger earnings and valuation, VSTM or OPK?

Verastem has higher earnings, but lower revenue than OPKO Health. OPKO Health is trading at a lower price-to-earnings ratio than Verastem, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Verastem	$10M	29.24	-$87.37M	-$3.50	-1.88
OPKO Health	$713.14M	1.70	-$188.86M	-$0.09	-20.00

Is VSTM or OPK more profitable?

Verastem has a net margin of 0.00% compared to OPKO Health's net margin of -18.65%. OPKO Health's return on equity of -9.76% beat Verastem's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Verastem	N/A	-332.73%	-73.97%
OPKO Health	-18.65%	-9.76%	-6.46%

Do insiders & institutionals have more ownership in VSTM or OPK?

88.4% of Verastem shares are owned by institutional investors. Comparatively, 64.6% of OPKO Health shares are owned by institutional investors. 2.2% of Verastem shares are owned by insiders. Comparatively, 47.3% of OPKO Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Verastem beats OPKO Health on 9 of the 17 factors compared between the two stocks.